We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Require Advance Notice of Potential Manufacturing Stoppages
FDA to Require Advance Notice of Potential Manufacturing Stoppages
November 6, 2013
Generic drug manufacturers must notify the FDA at least six months before they believe a product may be permanently discontinued or experience an interruption in manufacturing, according to a new proposed rule published Nov. 1.